Choose Language
Select a language for news translation.
Written by James Brumley for The Motley Fool -> CRISPR Therapeutics has developed a cutting-edge gene-editing biotechnology. Unlike many of its peers, CRISPR…
Corbus Pharmaceuticals appointed Leonardo Viana Nicacio as Chief Medical Officer to lead its oncology and obesity drug pipeline. His experience in designing an…
Written by Alex Carchidi for The Motley Fool -> Viking Therapeutics could have a medicine on the market within two years. To capture market share, the new offe…
In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes of Advanced Technology of the Chi…
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts . MapLight Therapeutics, Inc.
Written by Jonathan Ponciano for The Motley Fool -> The chief medical officer of Monte Rosa Therapeutics reported selling 41,845 shares directly for a transact…
(RTTNews) - Rani Therapeutics Holdings, Inc. (RANI) said on Monday that Chief Financial Officer Svai Sanford has stepped down.
Lori Anne Kunkel sold 10,000 Enliven Therapeutics shares for $345,000, reducing her stake by 16% as the stock rose 130% over a year. The sale, part of a prepla…
